Polarean Imaging new drug application gets FDA acceptance
23rd Dec 2020 11:38
(Sharecast News) - Medical imaging technology company Polarean Imaging updated the market on the status of its new drug application with the US Food and Drug Administration (FDA) on Wednesday.
Read morePolarean Imaging installs research unit at University of Kansas
18th Sep 2020 11:16
(Sharecast News) - Medical imaging technology company Polarean Imaging has installed its latest research unit order for a '9820 Xenon Polariser' system at the University of Kansas Medical Center, it announced on Friday.
Read morePolarean Imaging delivers and installs latest research unit order
24th Dec 2019 07:54
(Sharecast News) - Medical imaging technology company Polarean Imaging has delivered and installed its latest research unit order for a '9820 Xenon Polariser' system from the University of Iowa Hospitals and Clinics, it announced on Tuesday.
Read morePolarean delivers and installs new unit to University of BC
12th Nov 2019 16:02
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Tuesday that it has delivered and installed its latest research unit order for a '9820 Xenon Polariser' system from the University of British Columbia.
Read morePolarean Imaging completes enrolment for phase 3 trial
7th Nov 2019 11:51
(Sharecast News) - Medical imaging technology company Polarean Imaging, which has a proprietary magnetic resonance imaging (MRI) drug-device combination, announced on Thursday that the enrolment for its phase 3 non-inferiority clinical trials was now complete for both the lung transplant pathway and the lung resection pathway.
Read morePolarean Imaging revenues climb as clinical trial nears completion
27th Jun 2019 10:02
(Sharecast News) - Polarean Imaging's shares climbed on Thursday after reporting that its annual revenues doubled to come in slightly above expectations as sales in the US soared.
Read morePolarean names Charles Osborne as new CFO
29th Apr 2019 09:24
(Sharecast News) - Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.
Read morePolarean Imaging enters contract with University of British Columbia
15th Feb 2019 10:27
(Sharecast News) - Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on Friday, following the conclusion of UBC's procurement process.
Read moreTuesday broker round-up
11th Dec 2018 13:41
(Sharecast News) - ASOS: Morgan Stanley downgrades to underweight with a target price of 3,200p.
Read morePolarean Imaging progresses to Phase III trial of hyperpolarised 129-Xenon
23rd Aug 2018 14:53
(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Thursday that the first patient has been enrolled in its Phase III FDA clinical trial, which aims to demonstrate non-inferiority of its drug-device combination using hyperpolarised 129-Xenon (129Xe) gas MRI, against an approved comparator.
Read morePolarean upbeat on results of pilot study
27th Jul 2018 09:26
(Sharecast News) - Medical imaging technology company Polarean Imaging announced the allowance of the latest patents on polarisation, the results of a 'pilot study' that was undertaken in preparation for its upcoming phase III clinical trials, and an update regarding phase III trials on Friday.
Read more